Keegan BM - Search Results

1

MR Imaging Features of Critical Spinal Demyelinating Lesions Associated with Progressive Motor Impairment.

Keegan BM, Messina SA, Hanson D, Holmes D, Camp J, Sechi E, Nayak S, Barakat B, Ahmad R, Mandrekar J, Harmsen WS, Kantarci O, Weinshenker BG, Flanagan EP. Keegan BM, et al. AJNR Am J Neuroradiol. 2024 Jul 8;45(7):943-950. doi: 10.3174/ajnr.A8304. AJNR Am J Neuroradiol. 2024. PMID: 38754997

2

Contrasting effects of IFNbeta and IVIG in children with central and peripheral demyelination.

Pirko I, Kuntz NL, Patterson M, Keegan BM, Weinshenker BG, Rodriguez M. Pirko I, et al. Among authors: keegan bm. Neurology. 2003 May 27;60(10):1697-9. doi: 10.1212/01.wnl.0000064163.94122.eb. Neurology. 2003. PMID: 12771272

3

A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis.

Wingerchuk DM, Benarroch EE, O'Brien PC, Keegan BM, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M. Wingerchuk DM, et al. Among authors: keegan bm. Neurology. 2005 Apr 12;64(7):1267-9. doi: 10.1212/01.WNL.0000156803.23698.9A. Neurology. 2005. PMID: 15824361 Clinical Trial.

4

Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experience.

Miller RC, Lachance DH, Lucchinetti CF, Keegan BM, Gavrilova RH, Brown PD, Weinshenker BG, Rodriguez M. Miller RC, et al. Among authors: keegan bm. Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1178-86. doi: 10.1016/j.ijrobp.2006.06.014. Epub 2006 Sep 11. Int J Radiat Oncol Biol Phys. 2006. PMID: 16965867 Clinical Trial.

5

Laquinimod, a new oral drug for multiple sclerosis.

Keegan BM, Weinshenker BG. Keegan BM, et al. Lancet. 2008 Jun 21;371(9630):2059-60. doi: 10.1016/S0140-6736(08)60894-6. Lancet. 2008. PMID: 18572062 No abstract available.

6

Treatment of central neurogenic hyperventilation with plasma exchange.

Keegan BM, Weinshenker BG. Keegan BM, et al. J Neurol. 2008 Aug;255(8):1274. doi: 10.1007/s00415-008-0886-7. Epub 2008 Jul 7. J Neurol. 2008. PMID: 18592127 No abstract available.

7

Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease.

Siva A, Saip S, Altintas A, Jacob A, Keegan BM, Kantarci OH. Siva A, et al. Among authors: keegan bm. Mult Scler. 2009 Aug;15(8):918-27. doi: 10.1177/1352458509106214. Mult Scler. 2009. PMID: 19667020

8

Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.

Magaña SM, Pittock SJ, Lennon VA, Keegan BM, Weinshenker BG, Lucchinetti CF. Magaña SM, et al. Among authors: keegan bm. Arch Neurol. 2009 Aug;66(8):964-6. doi: 10.1001/archneurol.2009.152. Arch Neurol. 2009. PMID: 19667216 Free PMC article.

9

Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients.

Jacob A, Matiello M, Weinshenker BG, Wingerchuk DM, Lucchinetti C, Shuster E, Carter J, Keegan BM, Kantarci OH, Pittock SJ. Jacob A, et al. Among authors: keegan bm. Arch Neurol. 2009 Sep;66(9):1128-33. doi: 10.1001/archneurol.2009.175. Arch Neurol. 2009. PMID: 19752302

10

Gait apraxia in multiple sclerosis.

Abou Zeid NE, Weinshenker BG, Keegan BM. Abou Zeid NE, et al. Among authors: keegan bm. Can J Neurol Sci. 2009 Sep;36(5):562-5. doi: 10.1017/s0317167100008040. Can J Neurol Sci. 2009. PMID: 19831123

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters